A Clinical Comparison of Two Multifocal Toric Soft Contact Lenses
1 other identifier
interventional
36
1 country
1
Brief Summary
This study aims to compare the short-term clinical performance of the two study contact lenses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 24, 2024
CompletedFirst Submitted
Initial submission to the registry
May 24, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2024
CompletedResults Posted
Study results publicly available
August 11, 2025
CompletedAugust 11, 2025
May 1, 2024
4 months
May 24, 2024
May 30, 2025
July 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Subjective Distance Vision
Subjective Distance Vision will be measured on a scale from 0-100 (Where 0= Extremely poor. Intolerable. Lenses cannot be worn. 100= Excellent. Unaware of any visual loss).
At the end of 15 minutes of daily wear
Study Arms (2)
Lens A (omafilcon A)
EXPERIMENTALAll participants will wear lens A for 15 minutes (Period 1).
Lens B (comfilcon A)
EXPERIMENTALAll participants will wear lens B for 15 minutes (Period 2).
Interventions
Eligibility Criteria
You may qualify if:
- They are aged 35 years or over and have capacity to volunteer.
- They understand their rights as a subject and are willing to sign a Statement of Informed Consent.
- They are willing and able to follow the protocol.
- They agree not to participate in other clinical research for the duration of this study.
- They are currently wearing soft contact lenses or have done so within the past 12 months.
- They have a spherical prescription between +10.00 and -10.00DS inclusive, (based on the ocular refraction).
- They have astigmatism of between -0.75 and -5.75DC (based on the ocular refraction) in each eye.
- They have a reading addition component to their spectacle refraction of between +0.75 and +2.50DS.
- They can be satisfactorily fitted with the study lenses.
- They own a wearable pair of spectacles.
You may not qualify if:
- They have an ocular disorder which would normally contraindicate contact lens wear.
- They have a systemic disorder which would normally contra-indicate contact lens wear.
- They are using any topical medications such as eye drops or ointment.
- They have had cataract surgery.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
- They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
- They have eye or health conditions including immunosuppressive or infectious diseases which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or a history of anaphylaxis or severe allergic reaction.
- They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Manchester
Manchester, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jose A. Vega, OD, MSc, PhD
- Organization
- CooperVision, Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Carole Maldonado-Codina, PhD,MCOptom
Eurolens Research
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2024
First Posted
June 3, 2024
Study Start
April 24, 2024
Primary Completion
August 15, 2024
Study Completion
August 15, 2024
Last Updated
August 11, 2025
Results First Posted
August 11, 2025
Record last verified: 2024-05